YM150
YM150 is a pharmaceutical drug with 20 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
9
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
20 of 20 finished
0.0%
0 ended early
0
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes
A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects
A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body
A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery
Clinical Trials (20)
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes
A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects
A Study to Evaluate the Safety and Tolerability of YM150 in Healthy Caucasian and Japanese Male and Female Subjects, and to Assess the Effect That Gender May Have on Its Actions in the Body
A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery
Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy Subjects
A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities
A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet
A Study to Compare the Pharmacokinetics of YM150 Formulation-A and Formulation-B
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20